Reference
Patkowska E, et al. Reversible pulmonary arterial hypertension as a complication of dasatinib treatment, with efficacious and safe continuation of chronic myeloid leukaemia therapy with nilotinib. Hematologia 4: 76-83, No. 1, 2013 [Polish; summarised from an English abstract]. - Poland
Rights and permissions
About this article
Cite this article
Dasatinib. Reactions Weekly 1486, 13 (2014). https://doi.org/10.1007/s40278-014-8524-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-014-8524-x